Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,429 followers.

RT @GarbineLizeaga: Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer htt…

Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer https://t.co/oyMv3FIQ1a

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.